The Estrogen Myth: Potential Use of Gonadotropin-Releasing Hormone Agonists for the Treatment of Alzheimer's Disease

ISSN： 1174-5886

Source： Drugs in R&D, Vol.7, Iss.3, 2006-01, pp. : 187-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging gonadotropin-releasing hormone agonists

By Beyer Daniel Alexander Amari Feriel Thill Marc Schultze-Mosgau Askan Al-Hasani Safaa Diedrich Klaus Griesinger Georg

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 2, 2011-06 ,pp. : 323-340

Informa Healthcare

Access to resources Recommend Favorite

New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists

By Schultze-Mosgau Askan Griesinger Georg Altgassen Christopher von Otte Soeren Hornung Daniela Diedrich Klaus

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 9, 2005-09 ,pp. : 1085-1097

Informa Healthcare

Access to resources Recommend Favorite

Gonadotropin-releasing hormone agonists in breast cancer

Inpharma, Vol. 1, Iss. 1589, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Gonadotropin-Releasing Hormone Agonists and the Risks of Type 2 Diabetes and Cardiovascular Disease in Men with Prostate Cancer

By Saylor Philip J.

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 255-261

Adis International

Access to resources Recommend Favorite

A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review

By Jeng Cherng-Jye Chuang Linus Shen Jenta

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 767-773

Informa Healthcare

Access to resources Recommend Favorite